Oct 9 (Reuters) - Optiscan Imaging Ltd OIL.AX :
* GOT FEEDBACK FROM FDA INDICATING CO'S 510(K) PATHWAY REMAINS ON TRACK FOR USE OF INVIVAGE DEVICE IN ORAL CANCER SCREENING
* TO COMMENCE THIRD PARTY VALIDATION & VERIFICATION TESTING OF INVIVAGE DEVICE IN CURRENT QUARTER TO SUPPORT INTENDED 510(K) SUBMISSION